Cargando…
Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived
PURPOSE OF REVIEW: Chronic lymphocytic leukaemia is now recognised as a heterogenous disease with a variety of clinical outcomes. Here we summarise the way it is currently stratified according to genetic risk and patient characteristics and the treatment approaches used for these different subgroups...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072049/ https://www.ncbi.nlm.nih.gov/pubmed/32172299 http://dx.doi.org/10.1007/s11912-020-0893-0 |